Related Experiment Video

Updated: Aug 30, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Minocycline enhances MPTP toxicity to dopaminergic neurons

Lichuan Yang1, Shuei Sugama, Jason W Chirichigno

  • 1Neurochemistry and Neurodegenerative Disease Laboratory, Weill Medical College at Cornell University, New York, New York 10021, USA.

Journal of Neuroscience Research
|September 30, 2003
PubMed

Insights

Minocycline, known for neuroprotection, unexpectedly worsened Parkinson

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Minocycline demonstrates neuroprotective effects in various models, including ischemia, excitotoxicity, and neurodegenerative diseases like Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS).
  • 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that selectively damages dopaminergic (DA) neurons, inducing Parkinson's disease (PD)-like symptoms in animal models.

Purpose of the Study:

  • To investigate the efficacy of minocycline in protecting against MPTP-induced neurotoxicity in dopaminergic neurons.

Main Methods:

  • Administration of minocycline in rodent models exposed to MPTP.
  • Assessment of microglial activation and damage to nigrostriatal DA neurons.
  • Evaluation of dopamine (DA) and 1-methyl-4-phenylpridium (MPP+) uptake into striatal vesicles.

Main Results:

  • Minocycline successfully inhibited microglial activation in response to MPTP.
  • Despite inhibiting microglial activation, minocycline significantly exacerbated MPTP-induced DA neuron damage.
  • Evidence suggests minocycline interferes with DA and MPP+ uptake into striatal vesicles.

Conclusions:

  • Minocycline's neuroprotective properties do not extend to MPTP-induced Parkinson's disease models.
  • Minocycline may worsen MPTP neurotoxicity by inhibiting dopamine and MPP+ uptake.

More Related Videos

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...